Protopic
Drugtopical
Other names: tacrolimus ointment, FK506 ointment
NCT Number: NCT00106496
The purpose of the study is to determine the impact of topical corticosteroids on the safety and effectiveness of Protopic Ointment in the short-term treatment of moderate to severe Atopic Dermatitis and to compare the safety and effectiveness of Protopic Ointment to placebo in the long-term management of Atopic Dermatitis
Looking for future studies?
Notify Me2 year and older
All sexes
Interventional
Phase 4
Investigational Site, Birmingham, Alabama, United States
Study includes an interim short-term, open label period. Patients could also receive a second course of open label treatment dependent on disease exacerbation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
topical
Other names: tacrolimus ointment, FK506 ointment
topical
topical
Time frame: 2 weeks
Time frame: Day 4 through end of study
Astellas Pharma Inc
Industry
A Multi-Center Study to Assess the Impact of Topical Corticosteroids on the Safety and Efficacy of Protopic Ointment in the Short-Term Treatment of Atopic Dermatitis and to Assess Protopic in the Long-term Management of Atopic Dermatitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06324812
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT04365387
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Phoenix, Arizona, United States
View Trial DetailsNCT06173284
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Beijing, Beijing Municipality, China
View Trial DetailsNCT03422822
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis
Birmingham, Alabama, United States
View Trial Details